JACLYN LOUISE HENDERSON

Person

CAMBRIDGE, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 11,964,961
- Issue date Apr 23, 2024
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands
- Patent number 11,390,623
- Issue date Jul 19, 2022
- Pfizer Inc.
- Thomas Allen Chappie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors
- Patent number 11,312,713
- Issue date Apr 26, 2022
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic substituted imidazo[4,5-c]quinoline derivatives
- Patent number 11,161,844
- Issue date Nov 2, 2021
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 11,014,909
- Issue date May 25, 2021
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,696,658
- Issue date Jun 30, 2020
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands
- Patent number 10,590,128
- Issue date Mar 17, 2020
- Pfizer, Inc.
- Thomas Allen Chappie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,421,744
- Issue date Sep 24, 2019
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,093,655
- Issue date Oct 9, 2018
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine deriva...
- Patent number 10,039,753
- Issue date Aug 7, 2018
- Pfizer Inc.
- Karen Jean Coffman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,822,097
- Issue date Nov 21, 2017
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted...
- Patent number 9,695,171
- Issue date Jul 4, 2017
- Pfizer Inc.
- Paul Galatsis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors
- Patent number 9,642,855
- Issue date May 9, 2017
- Pfizer Inc.
- Paul Galatsis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,617,275
- Issue date Apr 11, 2017
- Pfizer Inc.
- Jotham Wadsworth Coe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,527,831
- Issue date Dec 27, 2016
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibi...
- Patent number 9,156,845
- Issue date Oct 13, 2015
- Pfizer Inc.
- Paul Galatsis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,139,561
- Issue date Sep 22, 2015
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,107,923
- Issue date Aug 18, 2015
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20240317713
- Publication date Sep 26, 2024
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION
- Publication number 20240208923
- Publication date Jun 27, 2024
- Jnana Therapeutics Inc.
- Dean G. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS
- Publication number 20210355117
- Publication date Nov 18, 2021
- Pfizer Inc.
- Michael Aaron BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20210300899
- Publication date Sep 30, 2021
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20200283407
- Publication date Sep 10, 2020
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINE DOPAMINE D3 LIGANDS
- Publication number 20200157098
- Publication date May 21, 2020
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES
- Publication number 20200039977
- Publication date Feb 6, 2020
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20190367485
- Publication date Dec 5, 2019
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS
- Publication number 20190047997
- Publication date Feb 14, 2019
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20190002439
- Publication date Jan 3, 2019
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20180200253
- Publication date Jul 19, 2018
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20180037571
- Publication date Feb 8, 2018
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20170165270
- Publication date Jun 15, 2017
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Imidazo[4,5-c]Quinoline And Imidazo[4,5-c][1,5]Naphthyridine...
- Publication number 20170073343
- Publication date Mar 16, 2017
- Pfizer Inc.
- Paul Galatsis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20170057947
- Publication date Mar 2, 2017
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL 3,4-DISUBSTITUTED-1H-PYRROLO[2,3-b]PYRIDINES AND 4,5-DISUBSTI...
- Publication number 20170002000
- Publication date Jan 5, 2017
- Pfizer Inc.
- Paul Galatsis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d]Pyrimidines As LRRK2 I...
- Publication number 20150366874
- Publication date Dec 24, 2015
- Pfizer Inc.
- Paul Galatsis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20150344490
- Publication date Dec 3, 2015
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20150291625
- Publication date Oct 15, 2015
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150196561
- Publication date Jul 16, 2015
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150175573
- Publication date Jun 25, 2015
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150005313
- Publication date Jan 1, 2015
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d] Pyrimidines As LRRK2...
- Publication number 20140005183
- Publication date Jan 2, 2014
- Paul Galatsis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

JACLYN LOUISE HENDERSON

Person

Patents Grantslast 30 patents

Heteroaromatic compounds and their use as dopamine D1 ligands

6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands

Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors

Cyclic substituted imidazo[4,5-c]quinoline derivatives

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine deriva...

Heteroaromatic compounds and their use as dopamine D1 ligands

3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted...

Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibi...

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Patents Applicationslast 30 patents

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION

NOVEL IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINE DOPAMINE D3 LIGANDS

CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

Novel Imidazo[4,5-c]Quinoline And Imidazo[4,5-c][1,5]Naphthyridine...

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

NOVEL 3,4-DISUBSTITUTED-1H-PYRROLO[2,3-b]PYRIDINES AND 4,5-DISUBSTI...

Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d]Pyrimidines As LRRK2 I...

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d] Pyrimidines As LRRK2...